G.Barekat Pharm (XTEH:BRKT1) Receivables Turnover : 1.60 (As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. G.Barekat Pharm's Revenue for the six months ended in Mar. 2017 was IRR20,679,266 Mil. G.Barekat Pharm's average Accounts Receivable for the six months ended in Mar. 2017 was IRR12,912,311 Mil. Hence, G.Barekat Pharm's Receivables Turnover for the six months ended in Mar. 2017 was 1.60.

G.Barekat Pharm Receivables Turnover Historical Data

The historical data trend for G.Barekat Pharm's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Receivables Turnover Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Receivables Turnover

1.60

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Receivables Turnover	-	1.60

Competitive Comparison of G.Barekat Pharm's Receivables Turnover

For the Biotechnology subindustry, G.Barekat Pharm's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G.Barekat Pharm's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Receivables Turnover falls into.

G.Barekat Pharm Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

G.Barekat Pharm's Receivables Turnover for the fiscal year that ended in Mar. 2017 is calculated as

	Receivables Turnover (A: Mar. 2017 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Mar. 2017 )	/ (	(Accounts Receivable (A: Mar. 2016 )	+	Accounts Receivable (A: Mar. 2017 ))	/	count )
=	20679266	/ (	(0	+	12912311)	/	1 )
=	20679266	/	12912311
=	1.60

G.Barekat Pharm's Receivables Turnover for the quarter that ended in Mar. 2017 is calculated as

	Receivables Turnover (Q: Mar. 2017 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2017 )	/ (	(Accounts Receivable (Q: Mar. 2016 )	+	Accounts Receivable (Q: Mar. 2017 ))	/	count )
=	20679266	/ (	(0	+	12912311)	/	1 )
=	20679266	/	12912311
=	1.60

G.Barekat Pharm (XTEH:BRKT1) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

G.Barekat Pharm Receivables Turnover Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines